Cargando…
Following Excitation/Inhibition Ratio Homeostasis from Synapse to EEG in Monogenetic Neurodevelopmental Disorders
Pharmacological options for neurodevelopmental disorders are limited to symptom suppressing agents that do not target underlying pathophysiological mechanisms. Studies on specific genetic disorders causing neurodevelopmental disorders have elucidated pathophysiological mechanisms to develop more rat...
Autores principales: | Geertjens, Lisa, van Voorst, Torben W., Bouman, Arianne, van Boven, Maaike A., Kleefstra, Tjitske, Verhage, Matthijs, Linkenkaer-Hansen, Klaus, Nadif Kasri, Nael, Cornelisse, L. Niels, Bruining, Hilgo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872324/ https://www.ncbi.nlm.nih.gov/pubmed/35205434 http://dx.doi.org/10.3390/genes13020390 |
Ejemplares similares
-
Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol
por: Geertjens, Lisa, et al.
Publicado: (2022) -
SETD1A Mediated H3K4 Methylation and Its Role in Neurodevelopmental and Neuropsychiatric Disorders
por: Wang, Shan, et al.
Publicado: (2021) -
The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective
por: Mossink, Britt, et al.
Publicado: (2020) -
Synaptotagmin-1 enables frequency coding by suppressing asynchronous release in a temperature dependent manner
por: Huson, Vincent, et al.
Publicado: (2019) -
Publisher Correction: Synaptotagmin-1 enables frequency coding by suppressing asynchronous release in a temperature dependent manner
por: Huson, Vincent, et al.
Publicado: (2019)